Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician?: Results from a population-based study

Cancer

Volumn 119, Issue 2, 2013, Pages 421-428

  Song, Lixin ^a   Chen, Ronald C ^a,b   Bensen, Jeannette T ^a,c   Knafl, George J ^a   Nielsen, Matthew E ^b   Farnan, Laura ^a   Wallen, Eric M ^b   Mishel, Merle ^a   Pruthi, Raj S ^b   Mohler, James L ^a,d   Godley, Paul A ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

age; cancer aggressiveness; decision making; localized prostate cancer; subjective affective factors

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CLINICAL DECISION MAKING; COHORT ANALYSIS; COMPARATIVE STUDY; DEMOGRAPHY; DOCTOR PATIENT RELATION; EUROPEAN AMERICAN; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT EDUCATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; TREATMENT PLANNING;

AGED; DECISION MAKING; DISEASE MANAGEMENT; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PHYSICIAN'S ROLE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84872060503     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27738     Document Type: Article

References (42)

1. Mohler JL, Armstrong AJ, Bahnson RR, et al. NCCN Clinical Practice Guidelines in Oncology-Prostate Cancer. Available at: http://www.nccn.org/ professionals/physician-gls/pdf/prostate.pdf. Accessed December 10, 2011.
2. Rosenfeld B, Roth AJ, Gandhi S, Penson D,. Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology. 2004; 13: 800-807.
3. Mishel MH, Germino BB, Belyea M, et al. Moderators of an uncertainty management intervention: for men with localized prostate cancer. Nurs Res. 2003; 52: 89-97.
4. Pickles T, Ruether JD, Weir L, Carlson L, Jakulj F,; SCRN Communication Team. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int. 2007; 100: 544-551.
5. Steginga SK, Occhipinti S, Dunn J, Gardiner RA, Heathcote P, Yaxley J,. The supportive care needs of men with prostate cancer (2000). Psychooncology. 2001; 10: 66-75.
6. Lintz K, Moynihan C, Steginga S, et al. Prostate cancer patients' support and psychological care needs: survey from a non-surgical oncology clinic. Psychooncology. 2003; 12: 769-783.
7. Hu JC, Elkin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: Results from CaPSURE. J Urol. 2004; 171 (2 pt 1): 703-707; discussion 707-708.
8. Davison BJ, So AI, Goldenberg SL,. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU Int. 2007; 100: 780-785.
9. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P,. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology. 2004; 63: 751-756.
10. Steginga SK, Turner E, Donovan J,. The decision-related psychosocial concerns of men with localised prostate cancer: targets for intervention and research. World J Urol. 2008; 26: 469-474.
11. Diefenbach MA, Dorsey J, Uzzo RG, et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002; 20: 55-62.
12. Gwede CK, Pow-Sang J, Seigne J, et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer. 2005; 104: 1381-1390.
13. Diefenbach MA, Mohamed NE,. Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatment. Cancer Invest. 2007; 25: 449-457.
14. Clark JA, Talcott JA,. Confidence and uncertainty long after initial treatment for early prostate cancer: survivors' views of cancer control and the treatment decisions they made. J Clin Oncol. 2006; 24: 4457-4463.
15. Makoul G, Clayman ML,. An integrative model of shared decision making in medical encounters. Patient Educ Couns. 2006; 60: 301-312.
16. Emanuel EJ, Emanuel LL,. Four models of the physician-patient relationship. JAMA. 1992; 267: 2221-2226.
17. Devettere RJ,. Practical Decision Making in Health Care Ethics:Cases and Concepts. 3rd ed. Washington, DC: Georgetown University Press; 2010.
18. Elkin EB, Kim SH, Casper ES, Kissane DW, Schrag D,. Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions. J Clin Oncol. 2007; 25: 5275-5280.
19. Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int. 2007; 100: 1254-1258.
20. Keating NL, Beth Landrum M, Arora NK, et al. Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol. 2010; 28: 4364-4370.
21. Charles C, Gafni A, Whelan T,. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997; 44: 681-692.
22. Crawford MJ, Rutter D, Manley C, et al. Systematic review of involving patients in the planning and development of health care. BMJ. 2002; 325: 1263.
23. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang C,. Treatment decision-making by men with localized prostate cancer: the influence of personal factors. Urol Oncol. 2003; 21: 93-100.
24. Sommers BD, Beard CJ, D'Amico AV, Kaplan I, Richie JP, Zeckhauser RJ,. Predictors of patient preferences and treatment choices for localized prostate cancer. Cancer. 2008; 113: 2058-2067.
25. Pinquart M, Duberstein PR,. Information needs and decision-making processes in older cancer patients. Crit Rev Oncol Hematol. 2004; 51: 69-80.
26. Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K,. Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol. 2010; 21: 1145-1151.
27. Entwistle V, Prior M, Skea ZC, Francis JJ,. Involvement in treatment decision-making: its meaning to people with diabetes and implications for conceptualisation. Soc Sci Med. 2008; 66: 362-375.
28. Eldh AC, Ekman I, Ehnfors M,. Considering patient non-participation in health care. Health Expect. 2008; 11: 263-271.
29. Schroeder JC, Bensen JT, Su LJ, et al. The North Carolina-Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes. Prostate. 2006; 66: 1162-1176.
30. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011.
31. Davison BJ, Goldenberg SL,. Decisional regret and quality of life after participating in medical decision-making for early-stage prostate cancer. BJU Int. 2003; 91: 14-17.
32. Wong F, Stewart DE, Dancey J, et al. Men with prostate cancer: influence of psychological factors on informational needs and decision making. J Psychosom Res. 2000; 49: 13-19.
33. Fischer M, Visser A, Voerman B, Garssen B, van Andel G, Bensing J,. Treatment decision making in prostate cancer: patients' participation in complex decisions. Patient Educ Couns. 2006; 63: 308-313.
34. Walsh MC, Trentham-Dietz A, Schroepfer TA, et al. Cancer information sources used by patients to inform and influence treatment decisions. J Health Commun. 2010; 15: 445-463.
35. Sidana A, Hernandez DJ, Feng Z, et al. Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate. 2012; 72: 58-64.
36. Zeliadt SB, Ramsey SD, Penson DF, et al. Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer. 2006; 106: 1865-1874.
37. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P,. Making decisions about treatment for localized prostate cancer. BJU Int. 2002; 89: 255-260.
38. Hall JD, Boyd JC, Lippert MC, Theodorescu D,. Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey. Urology. 2003; 61: 402-407.
39. Song L, Hamilton JB, Moore AD,. Patient-healthcare provider communication: perspectives of African American cancer patients [published online ahead of print September 5, 2011]. Health Psychol.
40. Sinfield P, Baker R, Agarwal S, Tarrant C,. Patient-centred care: what are the experiences of prostate cancer patients and their partners? Patient Educ Couns. 2008; 73: 91-96.
41. Christie KM, Meyerowitz BE, Giedzinska-Simons A, Gross M, Agus DB,. Predictors of affect following treatment decision-making for prostate cancer: conversations, cognitive processing, and coping. Psychooncology. 2009; 18: 508-514.
42. Albrecht TL, Eggly SS, Gleason ME, et al. Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol. 2008; 26: 2666-2673.